Healthcare Professionals
InterStim II Neurostimulator
Sacral Neuromodulation
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
Sacral Neuromodulation
The implanted InterStim™ II system electrically stimulates the sacral nerve which is thought to normalize neural communication between the bladder and brain1 and between the bowel and brain.2
InterStim Therapy for Urinary Control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
InterStim Therapy for Bowel Control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.
The InterStim II neurostimulator was developed to offer physicians a second choice of neurostimulators and to address a wider range of patient needs. The InterStim II neurostimulator is 37% smaller by displaced volume and almost 50% lighter by weight (22 g versus 42 g) than the InterStim neurostimulator model 3023. The InterStim II neurostimulator is intended for patients who will benefit from the use of a smaller implanted device, and who experience symptom control with low to moderate neurostimulation parameters.
The InterStim II neurostimulator streamlines the implant procedure with a design that eliminates the need for the lead extension and uses fewer set screws.
InterStim II model 3058 has FDA-approved labeling for 1.5 Tesla MRI head scans.
Refer to the MRI Guidelines for a complete list of conditions and instructions for use (available on the Medtronic Manuals Library).
Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (InterStim) or model number (3058). You may also call 800-961-9055 for a copy of a manual.
| Model | 3058 |
|---|---|
| Battery Type | Primary Cell |
| Weight | 22 g (0.77 oz) |
| Height | 44 mm (1.7 in) |
| Length | 51 mm (2.0 in) |
While the precise mechanism of action of SNM has not been fully established, efficacy has been proven in clinical studies.
Johnson M. Transcutaneous electrical nerve stimulation (TENS). Published online Oct 15, 2012.
Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100:959–968.